Exploring the latest evidence-based approaches to treating both deadly Plasmodium falciparum malaria and persistent non-falciparum species, highlighting scientific breakthroughs offering new hope.
Discover how cancers develop resistance to irreversible EGFR inhibitors through the IGF-1R pathway and the promising combination therapies being developed.
Explore how chemical biology is transforming our understanding of cancer drug resistance and developing innovative strategies to overcome it.